Target intelligence / Profile preview

Mitochondrially encoded tRNA lysine (MT-TK)

Target
MT-TK
Molecular classification
Transfer RNA (tRNA), Non-coding RNA, Mitochondrially encoded gene product, Other
01

Overview

Mitochondrially encoded tRNA lysine (MT-TK) is a small, non-coding transfer RNA encoded by the mitochondrial genome. It consists of 70 nucleotides and is responsible for delivering lysine to the growing polypeptide chain during mitochondrial translation. This RNA plays a critical role in the synthesis of proteins required for oxidative phosphorylation, the primary pathway through which mitochondria produce ATP. Mutations in the MT-TK gene, especially the m.8344A>G mutation, are causative for myoclonic epilepsy with ragged-red fibers (MERRF) syndrome and other mitochondrial diseases. Proper post-transcriptional modifications and structural folding of MT-TK are essential for its function and for the overall integrity of mitochondrial translation.

Other names
trnKtRNA^Lysmitochondrial tRNA-LysMTTKMERRF tRNA
02

Mechanism of action

Not applicable (no drugs are known to directly target mitochondrial tRNAs)

03

Biological functions

Mitochondrial protein synthesisAmino acid transport (lysine) during translationOxidative phosphorylation (indirectly, via synthesis of involved proteins)
04

Disease associations

Mitochondrial disease (notably Myoclonic Epilepsy with Ragged Red Fibers, MERRF)Other neuromuscular and metabolic mitochondrial disorders
05

Safety considerations

No direct therapeutic targeting; mutations can cause multisystemic mitochondrial diseases which are challenging to treat and monitortRNA modifications and proper folding are critical for cell viability; alterations can have severe, multi-organ consequences
06

Biomarkers

m.8344A>G mutation in the MT-TK gene is a biomarker for MERRF syndrome

Beyond the preview

Go deeper on Mitochondrially encoded tRNA lysine (MT-TK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrially encoded tRNA lysine (MT-TK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call